Saxagliptin

Results: 87



#Item
51The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

Add to Reading List

Source URL: www.fda.gov

Language: English
52The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

Add to Reading List

Source URL: www.fda.gov

Language: English
53The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

Add to Reading List

Source URL: www.fda.gov

Language: English
54The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

Add to Reading List

Source URL: www.fda.gov

Language: English
55The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

Add to Reading List

Source URL: www.fda.gov

Language: English
56The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

Add to Reading List

Source URL: www.fda.gov

Language: English
57Case 1:14-cv[removed]GMS Document 1 Filed[removed]Page 1 of 7 PageID #: 1  IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ASTRAZENECA AB, Plaintiff,

Case 1:14-cv[removed]GMS Document 1 Filed[removed]Page 1 of 7 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ASTRAZENECA AB, Plaintiff,

Add to Reading List

Source URL: patentdocs.typepad.com

Language: English - Date: 2014-07-28 00:35:39
58Commissioning Support DPP-4 inhibitors (‘Gliptins’): Sitagliptin (Januvia®), Vildagliptin (Galvus®), Saxagliptin (Onglyza®), Linagliptin (Trajenta®▼), Alogliptin (Vipidia®▼)

Commissioning Support DPP-4 inhibitors (‘Gliptins’): Sitagliptin (Januvia®), Vildagliptin (Galvus®), Saxagliptin (Onglyza®), Linagliptin (Trajenta®▼), Alogliptin (Vipidia®▼)

Add to Reading List

Source URL: centreformedicinesoptimisation.co.uk

Language: English - Date: 2014-07-11 10:26:59
59The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

Add to Reading List

Source URL: www.fda.gov

Language: English
60The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus

Add to Reading List

Source URL: www.fda.gov

Language: English